Ekiert Damian C, Bhabha Gira, Elsliger Marc-André, Friesen Robert H E, Jongeneelen Mandy, Throsby Mark, Goudsmit Jaap, Wilson Ian A
Department of Molecular Biology, Scripps Research Institute, 10550 North Torrey Pines Road, La Jolla, CA 92037, USA.
Science. 2009 Apr 10;324(5924):246-51. doi: 10.1126/science.1171491. Epub 2009 Feb 26.
Influenza virus presents an important and persistent threat to public health worldwide, and current vaccines provide immunity to viral isolates similar to the vaccine strain. High-affinity antibodies against a conserved epitope could provide immunity to the diverse influenza subtypes and protection against future pandemic viruses. Cocrystal structures were determined at 2.2 and 2.7 angstrom resolutions for broadly neutralizing human antibody CR6261 Fab in complexes with the major surface antigen (hemagglutinin, HA) from viruses responsible for the 1918 H1N1 influenza pandemic and a recent lethal case of H5N1 avian influenza. In contrast to other structurally characterized influenza antibodies, CR6261 recognizes a highly conserved helical region in the membrane-proximal stem of HA1 and HA2. The antibody neutralizes the virus by blocking conformational rearrangements associated with membrane fusion. The CR6261 epitope identified here should accelerate the design and implementation of improved vaccines that can elicit CR6261-like antibodies, as well as antibody-based therapies for the treatment of influenza.
流感病毒对全球公共卫生构成了重大且持续的威胁,目前的疫苗能使机体对与疫苗株相似的病毒分离株产生免疫力。针对保守表位的高亲和力抗体可为多种流感亚型提供免疫力,并抵御未来的大流行病毒。我们测定了与导致1918年H1N1流感大流行的病毒以及近期一例致命H5N1禽流感病例的主要表面抗原(血凝素,HA)形成复合物的广谱中和性人源抗体CR6261 Fab的晶体结构,分辨率分别为2.2埃和2.7埃。与其他已解析结构的流感抗体不同,CR6261识别HA1和HA2膜近端茎区中一个高度保守的螺旋区域。该抗体通过阻断与膜融合相关的构象重排来中和病毒。此处鉴定出的CR6261表位应能加速设计和研发出可引发类似CR6261抗体的改良疫苗,以及用于治疗流感的基于抗体的疗法。